McDermott Will & Emery and EY at the 2022 J.P. Morgan Healthcare Conference

Due to the rapid pace of change, life sciences companies are being forced to transform their business models, requiring greater focus on therapies or commercial models. Moving forward, companies will continue to use transactions as an important lever of transformation.

Join us for an in-depth look into the strategies and shifts in business models impacting life sciences companies and dealmakers. This forum will address creative dealmaking strategies for growth in biopharma and medical technology as well as business model transformations companies should consider as they enter new deals.

Additional sessions with the latest insights from industry leaders include (all times in PST):

Digital Health Pioneers Forum
January 10, 2022 | 10:45 am - 1:30 pm

Acceleration Capital Forum
January 11, 2022 | 12:15 - 1:15 pm
  
Healthcare Private Equity Leaders Forum
January 11, 2022 | 8:30 - 11:20 am

Hospital & Health Systems Forum
January 11, 2022 | 1:30 - 3:30 pm